| |
 |
SYM |
Description |
|
|
CNSO |
rEEG technology for the assessment of neurophysiological abnormalities and determination of psychiatric treatment |
 |
|
|
|
|
|
|
|
SURG |
Micro or minimally invasive products for ophthalmic and neurosurgery.
|
|
|
|
|
|
|
 |
|
CYKN |
Therapeutic neurotechnology procedures for the treatment of nervous system conditions, including spinal cord and peripheral nerve injury |
|
|
|
|
|
|
|
|
EVVV |
Edovascular technologies for interventional radiology, cardiology, and neurology therapies. |
|
|
|
|
|
|
|
|
Private |
Drugs for neurology, urology and cardiovascular diseases. |
|
|
|
|
|
|
|
|
Private |
Products for neurology, genetic disorders, haematology, nephrology, oncology and rheumatolgy. |
|
|
|
|
|
|
|
|
Private |
Contract research organization for clinical trials in oncology, neurology and diabetology. |
|
|
|
|
|
|
|
|
Private |
Gastroenterology, Neurology & Psychiatry and Pain Treatment. |
|
|
|
|
|
|
|
|
CMP |
Computer based diagnostic technologies in the areas of sleep, Neurology and Cardiology. |
|
|
|
|
|
|
|
|
Private |
Specialy pharmaceuticals for oncology, urology and neurology |
|
|
|
|
|
|
|
|
Private |
Pharmaceutical products, primarily in the areas of neurology, dermatology and infectious disease. |
|
|
|
|
|
|
|
|
SOMX |
Drugs for the areas of psychiatry and neurology. |
|
|
|
|
|
|
|
|
TAROF |
Dermatological products and a line of solid dosage products used mainly in cardiology and neurology. |
|
|
|
|
|
|
|
|
Private |
Products used for cardiology and neurology applications |
|
|
|
|
|
|
|
|
GLFD |
Products for neurology and hospital markets. |
|
|
|
|
|
|
|
|
|
Functional diagnostics in the field of urodynamics, gastroenterology and neurology. |
|
|
|
|
|
|
|
|
Private |
Implantable devices for the treatment of neurological disorders by responsive brain stimulation. |
|
|
|
|
|
|
|
|
CYBX |
Implantable medical devices for neurological disorders including epilepsy |
|
|
|
|
|
|
|
|
Private |
Real-time functional MRI technology to modify pain perception, addiction, and other psychological conditions
|
|
|
|
|
|
|
|
|
Private |
Treatment of neurologically based conditions of the retina, brain, spinal cord |
|
|
|
|
|
|
|
|
Private |
Technology for the management and treatment of neurological disorders. |
|
|
|
|
|
|
|
|
Private |
Drugs to treat serious neurological, psychiatric and pain disorders. |
|
|
|
|
|
|
|
|
Private |
Technology and products for reducing neurologic damage caused by cerebral ischemia. |
|
|
|
|
|
|
|
|
Private |
Noninvasive therapies to treat significant, chronic psychiatric and neurological disorders.
|
|
|
|
|
|
|
|
|
Private |
Medical devices for patients with neurological disabilities. |
|
|
|
|
|
|
|
|
Private |
Drug-device systems for local treatment of tumors and vascular, cardiac, and neurological diseases. |
|
|
|
|
|
|
|
|
Private |
Cell and gene based products for treatment of neurological diseases. |
|
|
|
|
|
|
|
|
Private |
Genetic therapeutics for the treatment of neurological disorders. |
|
|
|
|
|
|
|
|
CORT |
Drugs for the treatment of severe psychiatric and neurological diseases. |
|
|
|
|
|
|
|
|
Private |
Therapeutic products for neurodegenerative diseases, including Alzheimer's and Parkinson's disease |
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
OneMedPlace Member
